Sepsis
FDA Split On Approval Of Eli Lilly's Xigris
Published in Medical Letter on the CDC and FDA, November 11th, 2001
Some advisers to the U.S. Food and Drug Administration said Eli Lilly's Xigris appeared to fight the bloodstream infections, while others argued that it's impossible to tell how well the drug worked because the sickest patients were excluded from study.
Sepsis strikes about 750,000 Americans a year, at least 225,000 of whom die when the infection leads to complications that destroy their organs. Many illnesses can lead to sepsis, including trauma, surgical complications and pneumonia.
Patients are treated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Adverse Drug Effects
Infliximab Can Increase Tuberculosis Risk - Antibiotic Resistance
Drug-Resistant Pheumococcal Bacteria Increases With Overuse Of Drugs - AIDS And HIV Tuberculosis
Coinfection Increases HIV Replication - Dentistry
Little Evidence Fluoridation Reduces Tooth Decay - Funding
Congress Willing To Increase Money For U.S. Centers For Disease Control - Influenza
Healthy People Urged To Postpone Immunization Until November - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
